Data / Drug companies / Viatris Specialty LLC
Viatris Specialty LLC: 17 products in the FDA NDC directory, labeler code 0037
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Viatris Specialty LLC (labeler code 0037) lists 17 products in the FDA National Drug Code Directory, covering 13 finished drugs by generic name. By type: 16 prescription drugs, 1 over the counter drugs. Its main marketing category is new drug applications (NDA). The newest product started marketing on October 1, 2016.
The request: Watch Viatris Specialty LLC (FDA labeler code 0037): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 0037
- Products in commercial distribution
- 17
- Packages
- 19
- Finished drugs by generic name
- 13
- Prescription products
- 16
- Over the counter products
- 1
- Controlled substance products
- Schedule IV 4
- Flagged as original packager
- 17 of 17 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- November 30, 1978
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| New drug applications (NDA) | 13 | 76.5% |
| Generic drugs (ANDA) | 2 | 11.8% |
| Over the counter monograph drugs | 1 | 5.9% |
| Other unapproved drugs | 1 | 5.9% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 16 | 94.1% |
| Over the counter drugs | 1 | 5.9% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Zolpidem tartrate | 2 | 38 |
| Carisoprodol | 2 | 28 |
| Felbamate | 2 | 11 |
| Estradiol | 1 | 53 |
| Pramoxine hydrochloride | 1 | 15 |
| Penicillamine | 1 | 12 |
| Hydrocortisone acetate | 1 | 35 |
| Azelastine hydrochloride and fluticasone propionate | 1 | 4 |
| Pramoxine hydrochloride and hydrocortisone acetate | 1 | 1 |
| Pramoxine hydrochloride hydrocortisone acetate | 1 | 1 |
| Olsalazine sodium | 1 | 1 |
| Mesalamine | 1 | 41 |
| Cromolyn sodium | 1 | 11 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 8 | 47.1% |
| Aerosol, foam | 4 | 23.5% |
| Gel, metered | 1 | 5.9% |
| Spray, metered | 1 | 5.9% |
| Capsule, gelatin coated | 1 | 5.9% |
| Suspension | 1 | 5.9% |
| Liquid | 1 | 5.9% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Dymista | 0037-0245 | Spray, metered | New drug applications (NDA) | October 1, 2016 |
| Rowasa | 0037-0066 | Suspension | New drug applications (NDA) | March 24, 2016 |
| Cortifoam | 0037-6830 | Aerosol, foam | New drug applications (NDA) | June 15, 2015 |
| Dipentum | 0037-6860 | Capsule, gelatin coated | New drug applications (NDA) | May 15, 2015 |
| Gastrocrom | 0037-0678 | Liquid | New drug applications (NDA) | May 1, 2015 |
| Urelle | 0037-6321 | Tablet | Other unapproved drugs | January 12, 2015 |
| Epifoam | 0037-6824 | Aerosol, foam | Generic drugs (ANDA) | August 25, 2014 |
| Proctofoam ns | 0037-6823 | Aerosol, foam | Over the counter monograph drugs | August 18, 2014 |
| Proctofoam hc | 0037-6822 | Aerosol, foam | Generic drugs (ANDA) | August 15, 2014 |
| Elestrin | 0037-4801 | Gel, metered | New drug applications (NDA) | June 2, 2014 |
| Edluar | 0037-6050 | Tablet | New drug applications (NDA) | July 24, 2009 |
| Edluar | 0037-6010 | Tablet | New drug applications (NDA) | July 24, 2009 |
| Soma | 0037-2250 | Tablet | New drug applications (NDA) | September 8, 2007 |
| Soma | 0037-2001 | Tablet | New drug applications (NDA) | November 1, 1995 |
| Felbatol | 0037-0431 | Tablet | New drug applications (NDA) | July 29, 1993 |
| Felbatol | 0037-0430 | Tablet | New drug applications (NDA) | July 29, 1993 |
| Depen | 0037-4401 | Tablet | New drug applications (NDA) | November 30, 1978 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.